Recent News for CYTK - Cytokinetics, Incorporated

Date Title
Aug 9 A List Of Stocks Reaching New 52-Week Highs
Aug 9 Edited Transcript of CYTK earnings conference call or presentation 8-Aug-19 8:30pm GMT
Aug 9 Cytokinetics Inc (CYTK) Q2 2019 Earnings Call Transcript
Aug 9 Cytokinetics, Incorporated (CYTK) CEO Robert Blum on Q2 2019 - Earnings Call Transcript
Aug 9 Cytokinetics (CYTK) Reports Q2 Loss, Tops Revenue Estimates
Aug 8 Cytokinetics EPS misses by $0.06, beats on revenue
Aug 8 Cytokinetics Reports Second Quarter 2019 Financial Results
Aug 8 Stocks That Set New 52-Week Highs Thursday
Aug 8 The Daily Biotech Pulse: Glaukos To Buy Avedro, Mixed Adcom Vote For Gilead, Dynavax Offering
Aug 7 The Daily Biotech Pulse: Novartis Stands By Zolgensma, GW Pharma Q2 Propelled By Epidiolex Sales, Ionis-Akcea Clinical Readout
Jul 31 Cytokinetics Announces Preclinical Data for CK-3773274 Presented at the American Heart Association’s Basic Cardiovascular Sciences Scientific Sessions
Jul 29 Health Care Digest: Kilroy's Oyster Point mystery, helping researchers ditch spreadsheets — and more
Jul 28 Key events this week - healthcare
Jul 26 Does Cytokinetics, Incorporated (NASDAQ:CYTK) Have A Volatile Share Price?
Jul 25 First big lease lands at Kilroy's huge Oyster Point project
Jul 25 Cytokinetics to Announce Second Quarter Results on August 8, 2019
Jul 24 Cytokinetics Announces Publication of Preclinical Data Demonstrating Fast Skeletal Muscle Troponin Activator Improves Muscle Energetics
Jul 23 Cytokinetics Granted European Orphan Designation for Reldesemtiv for the Treatment of Spinal Muscular Atrophy
Jul 22 Cytokinetics Announces Preclinical Data Relating to CK-3773274 to be Presented at the American Heart Association’s Basic Cardiovascular Sciences Scientific Sessions
Jul 18 Analysts Estimate Cytokinetics (CYTK) to Report a Decline in Earnings: What to Look Out for
Jul 15 Cytokinetics Announces Completion of Enrollment in GALACTIC-HF, Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients With Heart Failure
Jul 8 Biophytis files for 8.75M-share U.S. IPO at $7-$9/ADS
Jun 28 Cytokinetics Announces Preclinical Data For Reldesemtiv Presented at the 2019 Annual Cure SMA Conference
Jun 27 Did Hedge Funds Drop The Ball On Cytokinetics, Inc. (CYTK) ?
Jun 24 Cytokinetics Announces Preclinical Data for Reldesemtiv to be Presented at the 2019 Annual Cure SMA Conference
Back to the Main CYTK Page...